A genetic confirmation typically follows the clinical diagnosis of RTT, but its role is still supportive, since mutations in MECP2 (the main RTT-associated gene) may cause other phenotypes than RTT, and mutations in other genes have been found in patients with a clinical diagnosis of RTT [4,6]. This evidence concerns the gene MECP2 and Rett syndrome.